About
Entera Bio Ltd (NASDAQ:ENTX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 14 2026
Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613
Apr 2 2026
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
Mar 27 2026
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
Mar 4 2026
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis
Feb 27 2026
Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board
Financials
Revenue
$42 K
Market Cap
$58.74 M
EPS
-0.25
Google Übersetzer